Page 128 - Read Online
P. 128

1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2   49.  Yang P, Yuan W, He J, Wang J, Yu L, Jin X, Hu Y, Liao M, Chen Z, Zhang
               tension. Proc Natl Acad Sci U S A 1995;92:5510-4.  Y. Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular
           29.  Luo D, Wang Z, Wu J, Jiang C, Wu J. The role of hypoxia inducible   carcinoma: Implications for tumor progression and prognosis. Hepatol Res
               factor-1 in hepatocellular carcinoma. Biomed Res Int 2014;2014:409272.  2009;39:1169-77.
           30.  Zhang L, Huang G, Li X, Zhang Y, Jiang Y, Shen J, Liu J, Wang Q, Zhu   50.  Zhang DH, Zhang LY, Liu DJ,  Yang F, Zhao JZ. Expression and
               J, Feng X, Dong J, Qian C. Hypoxia induces epithelial-mesenchymal   significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in
               transition via activation of SNAI1 by hypoxia-inducible factor -1alpha in   rats. Asian Pac J Trop Med 2014;7:585-8.
               hepatocellular carcinoma. BMC Cancer 2013;13:108.  51.  Chen X, Qiu J, Yang D, Lu J, Yan C, Zha X, Yin Y. MDM2 Promotes
           31.  Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D,   Invasion and Metastasis in Invasive Ductal Breast Carcinoma by Inducing
               Buechler P, Isaacs WB, Semenza GL, Simons JW. Overexpression of   Matrix Metalloproteinase-9. PLoS One 2013;8:e78794.
               hypoxia-inducible factor 1alpha in common human cancers and their   52.  Shi W, Meng Z, Chen Z, Hua Y, Gao H, Wang P, Lin J, Zhou Z, Luo
               metastases. Cancer Res 1999;59:5830-5.            J, Liu L. RNA interference against MDM2 suppresses tumor growth and
           32.  Tanaka H, Yamamoto M, Hashimoto N, Miyakoshi M,  Tamakawa S,   metastasis in pancreatic carcinoma SW1990HM cells. Mol Cell Biochem
               Yoshie M, Tokusashi Y, Yokoyama K, Yaginuma Y, Ogawa K. Hypoxia-  2014;387:1-8.
               independent overexpression of hypoxia-inducible factor 1alpha as an early   53.  Campos AR, Grossman D, White K. Mutant alleles at the locus elav in
               change in mouse hepatocarcinogenesis. Cancer Res 2006;66:11263-70.  Drosophila melanogaster lead to nervous system defects. A developmental-
           33.  Zheng SS, Chen XH, Yin X, Zhang BH. Prognostic significance of HIF-  genetic analysis. J Neurogenet 1985;2:197-218.
               1alpha expression in hepatocellular carcinoma: a meta-analysis. PLoS One   54.  Ma  WJ, Cheng S, Campbell C,  Wright A, Furneaux H. Cloning and
               2013;8:e65753.                                    characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol
           34.  Dai CX, Gao Q, Qiu SJ, Ju MJ, Cai MY, Xu YF, Zhou J, Zhang BH, Fan   Chem 1996;271:8144-51.
               J.  Hypoxia-inducible  factor-1  alpha,  in  association  with  inflammation,   55.  Srikantan S, Gorospe M. HuR function in disease. Front Biosci (Landmark
               angiogenesis and MYC, is a critical prognostic factor in patients with HCC   Ed) 2012;17:189-205.
               after surgery. BMC Cancer 2009;9:418.          56.  Dixon DA, Tolley ND, King PH, Nabors LB, McIntyre TM, Zimmerman
           35.  Yang SL, Liu LP, Jiang JX, Xiong ZF, He QJ, Wu C. The correlation   GA, Prescott SM. Altered expression of the mRNA stability factor HuR
               of  expression  levels of  HIF-1alpha  and HIF-2alpha in  hepatocellular   promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest
               carcinoma with capsular invasion, portal vein tumor thrombi and patients’   2001;108:1657-65.
               clinical outcome. Jpn J Clin Oncol 2014;44:159-67.  57.  Lopez de Silanes I, Lal A, Gorospe M. HuR: post-transcriptional paths to
           36.  Chen D, Li M, Luo J, Gu W. Direct interactions between HIF-1 alpha and   malignancy. RNA Biol 2005;2:11-3.
               Mdm2 modulate p53 function. J Biol Chem 2003;278:13595-8.  58.  Zhu H, Berkova Z, Mathur R, Sehgal L, Khashab T, Tao RH, Ao X, Feng
           37.  Nieminen AL, Qanungo S, Schneider EA, Jiang BH, Agani FH. Mdm2   L, Sabichi AL, Blechacz B, Rashid A, Samaniego F. HuR Suppresses Fas
               and HIF-1alpha interaction in tumor cells during hypoxia. J Cell Physiol   Expression and Correlates with Patient Outcome in Liver Cancer. Mol
               2005;204:364-9.                                   Cancer Res 2015;13:809-18.
           38.  Joshi S, Singh  AR, Durden DL. MDM2 regulates hypoxic hypoxia-  59.  Vazquez-Chantada M, Fernandez-Ramos D, Embade N, Martinez-Lopez
               inducible factor 1alpha stability in an E3 ligase, proteasome, and PTEN-  N, Varela-Rey M, Woodhoo A, Luka Z, Wagner C, Anglim PP, Finnell
               phosphatidylinositol 3-kinase-AKT-dependent manner.  J Biol Chem   RH, Caballería J, Laird-Offringa IA, Gorospe M, Lu SC, Mato JM,
               2014;289:22785-97.                                Martínez-Chantar ML. HuR/methyl-HuR and AUF1 regulate the MAT
           39.  Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q,   expressed during liver proliferation, differentiation, and carcinogenesis.
               Dillehay LE, Madan  A, Semenza GL, Bedi  A. Regulation of tumor   Gastroenterology 2010;138:1943-53.
               angiogenesis by p53-induced degradation of hypoxia-inducible factor   60.  Embade N, Fernandez-Ramos D,  Varela-Rey M, Beraza N, Sini M,
               1alpha. Genes Dev 2000;14:34-44.                  Gutierrez de Juan  V,  Woodhoo  A, Martínez-López N, Rodríguez-
           40.  Alves  CC,  Carneiro  F,  Hoefler  H,  Becker  KF.  Role  of  the  epithelial-  Iruretagoyena B, Bustamante FJ, de la Hoz AB, Carracedo A, Xirodimas
               mesenchymal transition regulator Slug in primary human cancers. Front   DP, Rodríguez MS, Lu SC, Mato JM, Martínez-Chantar ML. Murine
               Biosci (Landmark Ed) 2009;14:3035-50.             double minute 2 regulates Hu antigen R stability in human liver and colon
           41.  Zhao X, Sun B, Sun D, Liu T, Che N, Gu Q, Dong X, Li R, Liu Y, Li J.   cancer through NEDDylation. Hepatology 2012;55:1237-48.
               Slug promotes hepatocellular cancer cell progression by increasing sox2   61.  Gumbiner BM. Regulation of cadherin-mediated adhesion in
               and nanog expression. Oncol Rep 2015;33:149-56.   morphogenesis. Nat Rev Mol Cell Biol 2005;6:622-34.
           42.  Sun Y, Song GD, Sun N, Chen JQ, Yang SS. Slug overexpression induces   62.  Halbleib JM, Nelson  WJ. Cadherins in development: cell adhesion,
               stemness and promotes hepatocellular carcinoma cell invasion and   sorting, and tissue morphogenesis. Genes Dev 2006;20:3199-214.
               metastasis. Oncol Lett 2014;7:1936-40.         63.  Singhai R, Patil  VW, Jaiswal SR, Patil SD,  Tayade MB, Patil  AV.
           43.  Sun D, Sun B, Liu T, Zhao X, Che N, Gu Q, Dong X, Yao Z, Li R, Li   E-Cadherin as a diagnostic biomarker in breast cancer. N Am J Med Sci
               J, Chi J, Sun R. Slug promoted vasculogenic mimicry in hepatocellular   2011;3:227-33.
               carcinoma. J Cell Mol Med 2013;17:1038-47.     64.  Oka H, Shiozaki H, Kobayashi K,  Tahara H,  Tamura S, Miyata M,
           44.  Jung CH, Kim J, Park JK, Hwang SG, Moon SK, Kim WJ, Um HD.   Doki  Y, Iihara K, Matsuyoshi N, Hirano S,  Takeichi M, Mori  T.
               Mdm2 increases cellular invasiveness by binding to and stabilizing the   Immunohistochemical evaluation of E-cadherin adhesion molecule
               Slug mRNA. Cancer Lett 2013;335:270-7.            expression in human gastric cancer.  Virchows Arch A  Pathol Anat
           45.  Sternlicht MD,  Werb Z. How matrix metalloproteinases regulate cell   Histopathol 1992;421:149-56.
               behavior. Annu Rev Cell Dev Biol 2001;17:463-516.  65.  Bremnes RM, Veve R, Hirsch FR, Franklin WA. The E-cadherin cell-cell
           46.  Arii S, Mise M, Harada T, Furutani M, Ishigami S, Niwano M, Mizumoto   adhesion complex and lung cancer invasion, metastasis, and prognosis.
               M, Fukumoto M, Imamura M. Overexpression of matrix metalloproteinase   Lung Cancer 2002;36:115-24.
               9 gene in hepatocellular carcinoma with invasive potential. Hepatology   66.  Dorudi S, Sheffield JP, Poulsom R, Northover JM, Hart IR. E-cadherin
               1996;24:316-22.                                   expression in colorectal cancer.  An immunocytochemical and  in situ
           47.  Sakamoto Y, Mafune K, Mori M, Shiraishi T, Imamura H, Mori M, Shiraishi   hybridization study. Am J Pathol 1993;142:981-6.
               T, Imamura H, Mori M, Takayama T, Makuuchi M. Overexpression of   67.  von Burstin J, Eser S, Paul MC, Seidler B, Brandl M, Messer M, von
               MMP-9 correlates with growth of small hepatocellular carcinoma. Int J   Werder  A, Schmidt  A, Mages J, Pagel P, Schnieke  A, Schmid RM,
               Oncol 2000;17:237-43.                             Schneider  G,  Saur  D.  E-cadherin  regulates  metastasis  of  pancreatic
           48.  Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun   cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor
               BC. Promotion of hepatocellular carcinoma metastasis through matrix   complex. Gastroenterology 2009;137:361-71, 71 e1-5.
               metalloproteinase activation by epithelial-mesenchymal transition   68.  Asayama Y, Taguchi Ki K, Aishima Si S, Nishi H, Masuda K, Tsuneyoshi
               regulator Twist1. J Cell Mol Med 2011;15:691-700.  M.  The mode of tumour progression in combined hepatocellular

           119                                                              Hepatoma Research | Volume 2 | May 6, 2016
   123   124   125   126   127   128   129   130   131   132   133